Metabolism of deltamethrin and cis- and trans-permethrin by human expressed cytochrome P450 and carboxylesterase enzymes

References

• Achour B, Barber J, Rostami-Hodjegan A. (2014). Expression of hepatic drug-metabolizing cytochrome P450 enzymes and their intercorrelations: a meta-analysis. Drug Metab Dispos 42:1349–56.
   PubMed Web of Science ®Google Scholar
• Boberg M, Vrana M, Mehrotra A, et al. (2017). Age-dependent absolute abundance of hepatic carboxylesterases (CES1 and CES2) by LC-MS/MS proteomics: application to PBPK modeling of oseltamivir in vivo pharmacokinetics in infants. Drug Metab Dispos 45:216–23.
   PubMed Web of Science ®Google Scholar
• Crow JA, Borazjani A, Potter PM, Ross MK. (2007). Hydrolysis of pyrethroids by human and rat tissues: examination of intestinal, liver and serum carboxylesterases. Toxicol Appl Pharmacol 221:1–12.
   PubMed Web of Science ®Google Scholar
• Gammon DW, Chandrasekaran A, Elnaggar SF. (2012). Comparative metabolism and toxicology of pyrethroids in mammals. In: Marrs TC, ed. Issues in toxicology no 12, mammalian toxicology of insecticides. Cambridge, UK: RSC Publishing, 137–83.
   Google Scholar
• Godin SJ, Crow JA, Scollon EJ, et al. (2007). Identification of the rat and human cytochrome P450 isoforms and a rat serum esterase that metabolize the pyrethroid insecticides deltamethrin and esfenvalerate. Drug Metab Dispos 35:1664–71.
   PubMed Web of Science ®Google Scholar
• Godin SJ, DeVito MJ, Hughes MF, et al. (2010). Physiologically based pharmacokinetic modeling of deltamethrin: development of a rat and human diffusion-limited model. Toxicol Sci 115:330–43.
   PubMed Web of Science ®Google Scholar
• Godin SJ, Scollon EJ, Hughes MF, et al. (2006). Species differences in the in vitro metabolism of deltamethrin and esfenvalerate: differential oxidative and hydrolytic metabolism by humans and rats. Drug Metab Dispos 34:1764–71.
   PubMed Web of Science ®Google Scholar
• Hedges L, Brown S, Vardy A, et al. (2018). Metabolism of deltamethrin and cis- and trans-permethrin by rat and human liver microsomes, liver cytosol and plasma preparations. Xenobiotica. doi:10.1080/00498254.2018.1451011.
   Web of Science ®Google Scholar
• Hines RN. (2008). The ontogeny of drug metabolism enzymes and implications for adverse drug events. Pharmacol Therap 118:250–67.
   PubMed Web of Science ®Google Scholar
• Hines RN, Simpson PM, McCarver DG. (2016). Age-dependent human hepatic carboxylesterase 1 (CES1) and carboxylesterase 2 (CES2) postnatal ontogeny. Drug Metab Dispos 44:959–66.
   PubMed Web of Science ®Google Scholar
• Houston JB, Galetin A. (2008). Methods for predicting in vivo pharmacokinetics using data from in vitro assays. Curr Drug Metab 9:940–51.
   PubMed Web of Science ®Google Scholar
• Imai T, Taketani M, Shii M, et al. (2006). Substrate specificity of carboxylesterase isozymes and their contribution to hydrolase reactions in human liver and small intestine. Drug Metab Dispos 34:1734–41.
   PubMed Web of Science ®Google Scholar
• Jamei M, Marciniak S, Feng K, et al. (2009). The Simcyp population-based ADME simulator. Expert Opin Drug Metab Toxicol 5:211–23.
   PubMed Web of Science ®Google Scholar
• Kaneko H. (2011). Pyrethroids: mammalian metabolism and toxicity. J Agric Food Chem 59:2786–91.
   PubMed Web of Science ®Google Scholar
• Lawrence LJ, Casida JE. (1982). Pyrethroid toxicology: mouse intracerebral structure-toxicity relationships. Pest Biochem Physiol 18:9–14.
   Web of Science ®Google Scholar
• Lewis DFV, Ito Y. (2008). Cytochrome P450 structure and function: an evolutionary perspective. In: Ioannides C, ed. Cytochromes P450: role in the metabolism and toxicity of drugs and other xenobiotics. Cambridge, UK: RSC Publishing, 3–45.
   Google Scholar
• Mikata K, Isobe N, Kaneko H. (2012). Biotransformation and enzymatic reactions of synthetic pyrethroids in mammals. Top Curr Chem 314:113–35.
   PubMed Web of Science ®Google Scholar
• Nishi K, Huang H, Kamita SG, et al. (2006). Characterization of pyrethroid hydrolysis by the human liver carboxylesterases hCE-1 and hCE-2. Arch Biochem Biophys 445:115–23.
   PubMed Web of Science ®Google Scholar
• Pelkonen O, Turpeinen M, Hakkola J, et al. (2008). Inhibition and induction of human cytochrome P450 enzymes: current status. Arch Toxicol 82:667–715.
   PubMed Web of Science ®Google Scholar
• Proctor NJ, Tucker GT, Rostami-Hodjegan A. (2004). Predicting drug clearance from recombinantly expressed CYPs: intersystem extrapolation factors. Xenobiotica 34:151–78.
   PubMed Web of Science ®Google Scholar
• Rickard J, Brodie ME. (1985). Correlation of blood and brain levels of the neurotoxic pyrethroid deltamethrin with the onset of symptoms in rats. Pest Biochem Physiol 23:143–56.
   Web of Science ®Google Scholar
• Ross MK, Borazjani A, Edwards CC, Potter PM. (2006). Hydrolytic metabolism of pyrethroids by human and other mammalian carboxylesterases. Biochem Pharmacol 71:657–69.
   PubMed Web of Science ®Google Scholar
• Ross MK, Crow JA. (2007). Human carboxylesterases and their role in xenobiotic and endobiotic metabolism. J Biochem Mol Toxicol 21:187–96.
   PubMed Web of Science ®Google Scholar
• Sato Y, Miyashita A, Iwatsubo T, Usui T. (2012). Simultaneous absolute protein quantification of carboxylesterases 1 and 2 in human liver tissue fractions using liquid chromatography-tandem mass spectrometry. Drug Metab Dispos 40:1389–96.
   PubMed Web of Science ®Google Scholar
• Scollon EJ, Starr JM, Godin SJ, et al. (2009). In vitro metabolism of pyrethroid pesticides by rat and human hepatic microsomes and cytochrome P450 isoforms. Drug Metab Dispos 37:221–8.
   PubMed Web of Science ®Google Scholar
• Soderlund DM. (2012). Molecular mechanisms of pyrethroid insecticide neurotoxicity: recent advances. Arch Toxicol 86:165–81.
   PubMed Web of Science ®Google Scholar
• Soderlund DM, Clark JM, Sheets LP, et al. (2002). Mechanisms of pyrethroid neurotoxicity: implications for cumulative risk assessment. Toxicology 171:3–59.
   PubMed Web of Science ®Google Scholar
• Song G, Sun X, Hines RN, et al. (2017). Determination of human hepatic CYP2C8 and CYP1A2 age-dependent expression to support human health risk assessment for early ages. Drug Metab Dispos 45:468–75.
   PubMed Web of Science ®Google Scholar
• Stevens JC, Hines RN, Gu C, et al. (2003). Developmental expression of the major human hepatic CYP3A enzymes. J Pharmacol Exp Ther 307:573–82.
   PubMed Web of Science ®Google Scholar
• Tornero-Velez R, Davis J, Scollon EJ, et al. (2012). A pharmacokinetic model of cis- and trans-permethrin disposition in rats and humans with aggregate exposure application. Toxicol Sci 130:33–47.
   PubMed Web of Science ®Google Scholar
• Tsuji R, Yamada T, Kawamura S. (2012). Mammal toxicology of synthetic pyrethroids. Top Curr Chem 314:83–111.
   PubMed Web of Science ®Google Scholar
• Wang J, Williams ET, Bourgea J, et al. (2011). Characterization of recombinant human carboxylesterases: fluorescein diacetate as a probe substrate for human carboxylesterase 2. Drug Metab Dispos 39:1329–33.
   PubMed Web of Science ®Google Scholar
• Wetmore BA, Allen B, Clewell HJ, III, et al. (2014). Incorporating population variability and susceptible subpopulations into dosimetry for high-throughput toxicity testing. Toxicol Sci 142:210–24.
   PubMed Web of Science ®Google Scholar
• Yang D, Wang X, Chen Y-T, et al. (2009). Pyrethroid insecticides: isoform-dependent hydrolysis, induction of cytochrome P450 3A4 and evidence on the involvement of the pregnane X receptor. Toxicol Appl Pharmacol 237:49–58.
   PubMed Web of Science ®Google Scholar
• Yoon M, Campbell JL, Andersen ME, Clewell HJ. (2012). Quantitative in vitro to in vivo extrapolation of cell-based toxicity assay results. Crit Rev Toxicol 42:633–52.
   PubMed Web of Science ®Google Scholar
• Zhu HJ, Appel DI, Jiang Y, Markowitz JS. (2009). Age- and sex-related expression and activity of carboxylesterase 1 and 2 in mouse and human liver. Drug Metab Dispos 37:1819–25.
   PubMed Web of Science ®Google Scholar